AvantBio Corporation Management Team


Focusing on innovation, AvantBio leverages expertise in bioscience, biomedicine and chemistry to develop new products and processes for the therapeutic, bioresearch and chemical reagent markets.

Dr.Paul Cook Dr. Paul W. Cook, Ph. D., Co-founder, President & Chief Scientific Officer
Dr. Cook developed the first efficient, undefined and defined, animal origin-free (dAOF), normal human cell culture systems.
Dr. Rolf Winter Dr. Rolf W. Winter, Ph. D., Co-founder, Vice President, Director of Chemistry R&D
With over 100 organo-fluorine chemistry related publications to date, Dr. Winter has developed new and improved methods for the synthesis of Sulfur Fluorides and SF5-bearing aromatics.
Corey Jacklin Corey Jacklin, MBA, Vice President, Director of Business Development and Marketing
Corey joined AvantBio in September 2012 and is responsible for all commercial activities. Mr. Jacklin has sold platform enabling technologies to biotech and pharmaceutical companies and launched new technology for producing GMP cell culture derived products. Jacklin was also a co-founder of Polyprobe, acquired by Datascope in 1998; now operating independently as Genisphere. Mr. Jacklin holds a BS in Molecular Biology from the University of California, Berkeley and an MBA in Industrial Marketing from Baruch College, City University of New York.
Rob Harris Robert Harris, FCA, CEP, EA, Chief Financial Officer
‘Big 4’ trained Chartered Accountant with extensive career across public accounting, manufacturing and service industries in Europe and the USA. Past positions include VP of Finance and Corporate Controller for a NASDAQ listed company, CFO / Controller for a medical device start-up and Contract CFO / Controller for several entrepreneurial ventures.